MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33−0.01 (-0.75%)
Close on Nov 18, 2026Market cap $65.46MP/E –Yield –
MediciNova operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
MediciNova's operating income for the twelve months ending Jun 30, 2026 was -$11.85M. For fiscal 2025 it was -$13.28M. The highest annual figure on record is -$4.02M in fiscal 2013.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.28M | – |
| FY2024 | Dec 31, 2024 | -$12.68M | – |
| FY2023 | Dec 31, 2023 | -$9.90M | – |
| FY2022 | Dec 31, 2022 | -$14.63M | – |
| FY2021 | Dec 31, 2021 | -$10.22M | – |
| FY2020 | Dec 31, 2020 | -$14.18M | – |
| FY2019 | Dec 31, 2019 | -$14.03M | – |
| FY2018 | Dec 31, 2018 | -$15.59M | – |
| FY2017 | Dec 31, 2017 | -$13.03M | – |
| FY2016 | Dec 31, 2016 | -$10.88M | – |
| FY2015 | Dec 31, 2015 | -$8.82M | – |
| FY2014 | Dec 31, 2014 | -$9.22M | – |
| FY2013 | Dec 31, 2013 | -$4.02M | – |
| FY2012 | Dec 31, 2012 | -$10.95M | – |
| FY2011 | Dec 31, 2011 | -$16.11M | – |
| FY2010 | Dec 31, 2010 | -$17.88M | – |
| FY2009 | Dec 31, 2009 | -$21.24M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.54M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.84M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.09M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.38M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.61M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.18M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.31M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.05M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.14M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.49M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.15M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.30M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.96M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.23M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.90M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.41M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.10M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.31M | – |
| Q1 FY2021 | Mar 31, 2021 | -$201.53K | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.01M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.73M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.51M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.92M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.22M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.65M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.98M | – |
| Q4 FY2018 | Dec 31, 2018 | -$492.25K | – |
| Q3 FY2018 | Sep 30, 2018 | -$7.03M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.40M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.67M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.41M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.79M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.80M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.02M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.44M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.84M | – |
See a number that looks wrong?